Filing Details
- Accession Number:
- 0001562180-15-000077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-13 17:00:32
- Reporting Period:
- 2015-02-11
- Filing Date:
- 2015-02-13
- Accepted Time:
- 2015-02-13 17:00:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1271214 | Intersect Ent Inc. | XENT | Surgical & Medical Instruments & Apparatus (3841) | 200280837 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1614586 | Amy Wolbeck | C/O Intersect Ent, Inc. 1555 Adams Drive Menlo Park CA 94025 | V.p. Regulatory Affairs & Qlty | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-02-11 | 2,901 | $22.05 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-02-12 | 5,099 | $1.00 | 5,099 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-12 | 5,099 | $22.16 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-02-12 | 5,099 | $0.00 | 5,099 | $1.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,401 | 2019-02-02 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2014.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.11 to $22.37, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- The shares subject to the option are immediately exercisable. 25% of the shares subject to the option vested on January 5, 2010 and 1/48th of the shares subject to the option vests monthly thereafter over there (3) years.